Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

P-Glycoprotein Activity in Steroid-Responsive vs. Steroid-Resistant Nephrotic Syndrome.

Badr HS, El-Hawy MA, Helwa MA.

Indian J Pediatr. 2016 Nov;83(11):1222-1226. Epub 2016 May 19.

PMID:
27193461
2.

Expression of P-glycoprotein in lymphocytes of children with nephrotic syndrome treated with glucocorticoids.

Wasilewska AM, Zoch-Zwierz WM, Pietruczuk M.

Eur J Pediatr. 2006 Dec;165(12):839-44.

PMID:
16738866
3.

Expression of multidrug resistance P-glycoprotein on lymphocytes from nephrotic children treated with cyclosporine A and ACE-inhibitor.

Wasilewska A, Zoch-Zwierz W, Pietruczuk M.

Eur J Pediatr. 2007 May;166(5):447-52. Epub 2006 Sep 22.

PMID:
17024347
4.

The relationship between renal P-glycoprotein expression and response to steroid therapy in childhood nephrotic syndrome.

Türkmen M, Torun Bayram M, Soylu A, Özer E, Sarıoğlu S, Kavukçu S.

Turk J Pediatr. 2013 May-Jun;55(3):260-5.

PMID:
24217071
5.

Expression of P-glycoprotein in lymphocytes from children with nephrotic syndrome, depending on their steroid response.

Wasilewska A, Zoch-Zwierz W, Pietruczuk M, Zalewski G.

Pediatr Nephrol. 2006 Sep;21(9):1274-80. Epub 2006 Jun 8.

PMID:
16761159
6.

Cyclosporine in the treatment of childhood idiopathic steroid resistant nephrotic syndrome: a single centre experience in Nigeria.

Ladapo TA, Esezobor CI, Lesi FE.

Pan Afr Med J. 2016 Dec 29;25:258. doi: 10.11604/pamj.2016.25.258.9802. eCollection 2016.

8.

P-glycoprotein overexpression in bone marrow-derived multipotent stromal cells decreases the risk of steroid-induced osteonecrosis in the femoral head.

Han N, Li Z, Cai Z, Yan Z, Hua Y, Xu C.

J Cell Mol Med. 2016 Nov;20(11):2173-2182. doi: 10.1111/jcmm.12917. Epub 2016 Jul 11.

9.

Dexamethasone increases expression and activity of multidrug resistance transporters at the rat blood-brain barrier.

Narang VS, Fraga C, Kumar N, Shen J, Throm S, Stewart CF, Waters CM.

Am J Physiol Cell Physiol. 2008 Aug;295(2):C440-50. doi: 10.1152/ajpcell.00491.2007. Epub 2008 Jun 4.

10.

Multi-drug resistance-1 gene polymorphisms in nephrotic syndrome: impact on susceptibility and response to steroids.

Youssef DM, Attia TA, El-Shal AS, Abduelometty FA.

Gene. 2013 Nov 10;530(2):201-7. doi: 10.1016/j.gene.2013.08.045. Epub 2013 Aug 27.

PMID:
23994685
11.

Urine Neutrophil Gelatinase Associated Lipocalin to Creatinine Ratio: A Novel Index for Steroid Response in Idiopathic Nephrotic Syndrome.

Nickavar A, Safaeian B, Sadeghi-Bojd S, Lahouti Harah dashti A.

Indian J Pediatr. 2016 Jan;83(1):18-21. doi: 10.1007/s12098-015-1809-0. Epub 2015 Jun 23.

PMID:
26096867
13.

Serum Tumor Necrosis Factor-Alpha Levels in Children with Nephrotic Syndrome: A Pilot Study.

Weissbach A, Garty BZ, Lagovsky I, Krause I, Davidovits M.

Isr Med Assoc J. 2017 Jan;19(1):30-33.

14.

Differential alteration in peripheral T-regulatory and T-effector cells with change in P-glycoprotein expression in Childhood Nephrotic Syndrome: A longitudinal study.

Prasad N, Jaiswal AK, Agarwal V, Yadav B, Sharma RK, Rai M, Singh H, Chaturvedi S, Singh A.

Cytokine. 2015 Apr;72(2):190-6. doi: 10.1016/j.cyto.2014.12.028. Epub 2015 Feb 4.

PMID:
25661194
15.

MDR-1 and CYP3A5 Polymorphisms in Pediatric Idiopathic Nephrotic Syndrome: Impact on Susceptibility and Response to Steroids (Preliminary Results).

Moussa A, Mabrouk S, Hamdouni H, Ajmi M, Tfifha M, Omezzine A, Abroug S, Bouslama A.

Clin Lab. 2017 Jul 1;63(7):1233-1242. doi: 10.7754/Clin.Lab.2017.170203.

PMID:
28792718
16.

Follow-up of steroid-resistant nephrotic syndrome: tubular proteinuria and enzymuria.

Vallés P, Peralta M, Carrizo L, Martin L, Principi I, Gonzalez A, Manucha W.

Pediatr Nephrol. 2000 Dec;15(3-4):252-8.

PMID:
11149121
17.

[Clinical application of tacrolimus with low-dose prednisone in 21 children with steroid-resistant nephrotic syndrome].

Yao SH, Mao JH, Xia YH, Wang DY, Chen YF, Fang CQ, Liu AM, Du LZ.

Zhonghua Er Ke Za Zhi. 2011 Nov;49(11):825-8. Chinese.

PMID:
22336304
18.

β-Asarone promotes Temozolomide's entry into glioma cells and decreases the expression of P-glycoprotein and MDR1.

Wang N, Zhang Q, Ning B, Luo L, Fang Y.

Biomed Pharmacother. 2017 Jun;90:368-374. doi: 10.1016/j.biopha.2017.03.083. Epub 2017 Apr 2.

PMID:
28380412
19.

Transport of phosphatidylcholine in MDR3-negative epithelial cell lines via drug-induced MDR1 P-glycoprotein.

Abulrob AG, Gumbleton M.

Biochem Biophys Res Commun. 1999 Aug 19;262(1):121-6.

PMID:
10448079
20.

Oxidative modification of low-density lipoprotein in relation to dyslipidemia and oxidant status in children with steroid sensitive nephrotic syndrome.

El-Melegy NT, Mohamed NA, Sayed MM.

Pediatr Res. 2008 Apr;63(4):404-9. doi: 10.1203/PDR.0b013e3181647af5.

PMID:
18356747

Supplemental Content

Support Center